Antihyperuricemic Effects of Cornus officinalis Extract via URAT1 Regulation and Renoprotective Mechanisms
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26209980 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Yoon-Young Sung und 3 weiteren Autor:innen. Beteiligte Einrichtung: KM Science Research Division, Korea Institute of Oriental Medicine, 1672 Yuseongdae-ro, Yuseong-gu, Daejeon 34054, Republic of Korea. Hauptthemen laut MEDLINE: Cornus, Plant Extracts, Hyperuricemia, Organic Anion Transporters. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Korea Institute of Oriental Medicine.
Abstract (Originalsprache)
Hyperuricemia, characterized by elevated serum uric acid levels, is a major risk factor for gout and kidney disease. This study evaluated the antihyperuricemic effects of Cornus officinalis extract (COE) using urate transporter 1 (URAT1)-expressing oocytes and a hyperuricemia rat model. COE effectively inhibited uric acid absorption by modulating URAT1, with an IC50 value of 3.24 µg/mL. In the hyperuricemia model, COE administration (100 and 200 mg/kg) significantly reduced serum uric acid levels and increased urinary uric acid excretion. The primary constituents of COE, morroniside (MO) and loganin (LO) exerted similar effects, with MO exhibiting potent inhibition of uric acid absorption even at low concentrations. Kidney tissue analysis revealed a reduction in blood urea nitrogen (BUN) levels, indicating improved renal function. Liver function parameters (ALT, AST, and LDH) remained unchanged, suggesting an absence of hepatotoxicity. Ultra-high-performance liquid chromatography with charged aerosol detection (UHPLC-CAD) analysis identified MO (17.8 mg/g), LO (9.8 mg/g), and cornin (1.4 mg/g) as the principal components of COE. These findings suggest that COE enhances uric acid excretion via URAT1 regulation and exerts renoprotective effects, highlighting its potential as an antihyperuricemic agent. Furthermore, MO and LO were identified as the primary active constituents, and COE appears to be a promising therapeutic candidate with a favorable safety profile.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- KM Science Research Division, Korea Institute of Oriental Medicine, 1672 Yuseongdae-ro, Yuseong-gu, Daejeon 34054, Republic of Korea.
- DJU Industry-University Cooperation Foundation, Daejeon University, 62 Daehak-ro, Dong-gu, Daejeon 34520, Republic of Korea.
ORCID-Profile: Yoon-Young Sung, Dong-Seon Kim, Seung-Hyung Kim, Heung Joo Yuk
Förderung
- National Research Foundation of Korea
- Korea Institute of Oriental Medicine
Zitieren
APA
Sung, Y. Y., Kim, D. S., Kim, S. H., & Yuk, H. J. (2025). Antihyperuricemic Effects of Cornus officinalis Extract via URAT1 Regulation and Renoprotective Mechanisms. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26209980
Vancouver
Sung YY, Kim DS, Kim SH, Yuk HJ. Antihyperuricemic Effects of Cornus officinalis Extract via URAT1 Regulation and Renoprotective Mechanisms. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26209980
BibTeX
@article{Sung2025,
author = {Sung, Yoon-Young and Kim, Dong-Seon and Kim, Seung-Hyung and Yuk, Heung Joo},
title = {Antihyperuricemic Effects of Cornus officinalis Extract via URAT1 Regulation and Renoprotective Mechanisms},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26209980}
}
EUVIMED